Biotechnology Stock in Focus; Neuralstem Inc. (CUR) – SmallCap Network
By Dr. Matthew Watson
 Daily Mail | Biotechnology Stock in Focus; Neuralstem Inc. (CUR) SmallCap Network Shares of Neuralstem Inc. (AMEX: CUR) surged in trading on Thursday after the biotechnology company announced that its neural stem cells were part of a study published online in a leading scientific journal CELL. In the study, called Long Distance ... Neuralstem Gains on Stem Cell Therapy for Paralyzed RatsBusinessweek |
Source:
http://news.google.com/news?q=biotechnology&output=rss
Uncategorized
Comments Off on Biotechnology Stock in Focus; Neuralstem Inc. (CUR) – SmallCap Network |
September 16th, 2012
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research